

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+13.86%
-4.42%
+2.74%
-0.30%
-2.79%
ARGX
argenx SE American
$818.50
Strengths

Earnings are forecast to grow

Outperform the market
Chart
$787.94 (+3.88%)
$661.83 (+23.67%)
$574.96 (+42.36%)
$595.04 (+37.55%)
ARGX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Low volume

ARGX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
ARGX Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ARGX Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayARGX Earnings
The TTM reflects 12-month period, providing review of ARGX financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is ARGX current stock price?
What are ARGX stock strengths?
What risks are associated with ARGX stock?
When is ARGX next earnings report?
What is ARGX market cap and volume?
What is ARGX's current Stock IQ?
Should I buy ARGX stock right now?
Is ARGX a Strong Buy right now?
What does a 'Strong Buy' rating mean for ARGX?
What does a 'Strong Sell' rating mean for ARGX?
What factors influence ARGX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+13.86%
-4.42%
+2.74%
-0.30%
-2.79%
ARGX
argenx SE American
Current Price
$818.50
Stock Insights
Strengths

Earnings are forecast to grow

Outperform the market
Chart
$787.94 (+3.88%)
$661.83 (+23.67%)
$574.96 (+42.36%)
$595.04 (+37.55%)
ARGX Analysts Opinion
ARGX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
ARGX Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ARGX Street view is bullish and have positive views on the near-term outlook
ARGX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Low volume

Average key support and resistance price levels.
ARGX Earnings
The TTM data reflects the most recent 12-month period, providing overview of ARGX financial performance.
ARGX Financial Health
The company financial health has moderately improved over the past year
Financial Score
ARGX Latest Analysis
HC Wainwright & Co. Maintains argenx SE - Depositary Receipt (ARGX) Buy Recommendation. Fintel reports that on October 31 2025 HC Wainwright &. Co. maintained coverage of argenx SE - Depositary Receipt (NasdaqGS:ARGX) with a Buy recommendation. Analyst Price Forecast Suggests 5.63% Upside
Fri Oct 31, 2025
argenx SE beats top-line and bottom-line estimates. reaffirms FY25 outlook.
Thu Oct 30, 2025
Citi Remains ish on Argenx SE (ARGX). Argenx SE (NASDAQ:ARGX) is one of the most profitable biotech stocks to buy. Citi analyst Samantha Semenkow maintained a Buy rating on Argenx SE (NASDAQ:ARGX) on October 23 and set a price target of $1041. Argenx SE (NASDAQ:ARGX) also received a rating update from Bank of America Securities analyst Tazeen Ahmad who reiterated a Buy [….]
Tue Oct 28, 2025
argenx Reaches Analyst Target Price. In recent trading shares of argenx SE (Symbol: ARGX) have crossed above the average analyst 12-month target price of $826.86 changing hands for $837.28/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade on valuatio
Fri Oct 17, 2025
Wedbush Maintains argenx SE - Depositary Receipt (ARGX) Outperform Recommendation. Fintel reports that on October 13 2025 Wedbush maintained coverage of argenx SE - Depositary Receipt (NasdaqGS:ARGX) with a Outperform recommendation. Analyst Price Forecast Suggests 6.72% Upside
Tue Oct 14, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ARGX Stock trends
ARGX Stock performance
ARGX Stock analysis
ARGX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.